David Perry, Esq.

The Ticktin Law Group

Patent Attorney

Contact Information:

DPerry@LegalBrains.com

Education:

University of New Hampshire Franklin Pierce School of Law, Juris Doctor 2021
University of Central Florida, Masters of Science in Biotechnology 2020
Rollins College, Bachelor of Arts in Biochemistry & Molecular Biology 2013

Bar Admission:

United States Patent and Trademark Office (“USPTO”)
Florida

Publications

Paciaroni NG., Perry, DL., Norwood VM., Murillo-Solano C., Collins J., Tenneti, S., Chakrabarti D., Huigens RW. Re-Engineering of Yohimbine’s Biological Activity through Ring Distortion: Identification and Structure-Activity Relationships of a New Class of Antiplasmodial Agents.ACS Infect. Dis. 2020, 6(2):159-67. 

Perry DL, Roberts BR, Debevec G, Michaels HA, Chakrabarti D, Nefzi A. Identification of Bis-Cyclic Guanidines as Antiplasmodial Compounds from Positional Scanning Mixture-Based Libraries. Molecules 2019, 24(6):1100.

Noorwood VM 4th, Murillo-Solano C, Goertzen MG 2nd, Brummel BR, Perry DL, Rocca Jr, Chakrabarti D, Huigens RW 3rd. Ring Distortion of Vincamine Leads to the Identification of Re-Engineered Antiplasmodial Agents. ACS Omega. 2021, 6(31):20455-20470

Areas of Practice

Intellectual Property Law

David has always been fascinated by human innovation. During his childhood, David marveled at the beauty of the interchangeable part as he watched his grandfather repair automobiles in his repair shop. As such, from a young age David was drawn to science and technology. 

David continued with his passion for science and technology leading him to study Biochemistry at Rollins College. During his undergraduate studies, David’s research involving familial Parkinson’s disease led to him receiving the Clint Scholar (Outstanding Research Student.) 

David later went on to obtain a master’s degree in biotechnology. During his graduate studies, he worked on discovering next generation anti-malarial drugs from natural product and natural product inspired libraries. Much of his work involved characterized inhibitor mechanism of action against Plasmodium, the causative agent of Malaria, utilizing skills such as comparative genomics, cytotoxicity screening, flow cytometry, confocal microscopy, and immunofluorescence. David’s work has been published in multiple journals such as the American Chemical Society and Molecules. 

David’s research brought him to numerous national and international drug discovery conferences. Through his interactions with fellow researchers as well as pharmaceutical giants, David developed a keen interest in intellectual property law in order to bring innovative ideas from out of the shadows of research laboratories and into public light.

David’s interest in intellectual property law ultimately drove him to attend UNH Franklin Pierce School of Law, a school well known as being an “intellectual property powerhouse.” While in law school, David was recognized as an Atlantic regional champion by the United States Patent and Trademark Office in the USPTO’s 2020 National Patent Drafting Competition. (USPTO announces winners of the National Patent Drafting Competition | USPTO)

 David is a registered patent attorney with the USPTO and is licensed to practice law in the state of Florida. His previous work involved both patent and trademark prosecution. 

David is a proud member of the Knights of Columbus. On his time off, David assists in KoC activities such as road clean ups, fundraising, and more.